These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1319 related articles for article (PubMed ID: 22445098)

  • 1. Molecular mechanisms of hypertension--reactive oxygen species and antioxidants: a basic science update for the clinician.
    Montezano AC; Touyz RM
    Can J Cardiol; 2012 May; 28(3):288-95. PubMed ID: 22445098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities.
    Paravicini TM; Touyz RM
    Diabetes Care; 2008 Feb; 31 Suppl 2():S170-80. PubMed ID: 18227481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative stress, Noxs, and hypertension: experimental evidence and clinical controversies.
    Montezano AC; Touyz RM
    Ann Med; 2012 Jun; 44 Suppl 1():S2-16. PubMed ID: 22713144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactive oxygen species and vascular biology: implications in human hypertension.
    Touyz RM; Briones AM
    Hypertens Res; 2011 Jan; 34(1):5-14. PubMed ID: 20981034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reactive oxygen species and endothelial function--role of nitric oxide synthase uncoupling and Nox family nicotinamide adenine dinucleotide phosphate oxidases.
    Montezano AC; Touyz RM
    Basic Clin Pharmacol Toxicol; 2012 Jan; 110(1):87-94. PubMed ID: 21883939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanisms of hypertension: role of Nox family NADPH oxidases.
    Sedeek M; Hébert RL; Kennedy CR; Burns KD; Touyz RM
    Curr Opin Nephrol Hypertens; 2009 Mar; 18(2):122-7. PubMed ID: 19430333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting reactive oxygen species in hypertension.
    Cifuentes ME; Pagano PJ
    Curr Opin Nephrol Hypertens; 2006 Mar; 15(2):179-86. PubMed ID: 16481886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reactive oxygen species, vascular Noxs, and hypertension: focus on translational and clinical research.
    Montezano AC; Touyz RM
    Antioxid Redox Signal; 2014 Jan; 20(1):164-82. PubMed ID: 23600794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is oxidative stress a therapeutic target in cardiovascular disease?
    Münzel T; Gori T; Bruno RM; Taddei S
    Eur Heart J; 2010 Nov; 31(22):2741-8. PubMed ID: 20974801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular NADPH oxidases as drug targets for novel antioxidant strategies.
    Guzik TJ; Harrison DG
    Drug Discov Today; 2006 Jun; 11(11-12):524-33. PubMed ID: 16713904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel therapeutic approaches in limiting oxidative stress and inflammation.
    Spychalowicz A; Wilk G; Śliwa T; Ludew D; Guzik TJ
    Curr Pharm Biotechnol; 2012 Oct; 13(13):2456-66. PubMed ID: 22280420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The molecular sources of reactive oxygen species in hypertension.
    Puddu P; Puddu GM; Cravero E; Rosati M; Muscari A
    Blood Press; 2008; 17(2):70-7. PubMed ID: 18568695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidative stress in the cardiovascular center has a pivotal role in the sympathetic activation in hypertension.
    Hirooka Y
    Hypertens Res; 2011 Apr; 34(4):407-12. PubMed ID: 21346766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tracing the origins of postoperative atrial fibrillation: the concept of oxidative stress-mediated myocardial injury phenomenon.
    Elahi MM; Flatman S; Matata BM
    Eur J Cardiovasc Prev Rehabil; 2008 Dec; 15(6):735-41. PubMed ID: 19020458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelin-1-induced oxidative stress in DOCA-salt hypertension involves NADPH-oxidase-independent mechanisms.
    Callera GE; Tostes RC; Yogi A; Montezano AC; Touyz RM
    Clin Sci (Lond); 2006 Feb; 110(2):243-53. PubMed ID: 16271043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactive oxygen species and glucocorticoid-induced hypertension.
    Ong SL; Zhang Y; Whitworth JA
    Clin Exp Pharmacol Physiol; 2008 Apr; 35(4):477-82. PubMed ID: 18307745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is mycophenolate more than just an immunosuppressant?--An overview.
    Iyer A; Brown L
    Indian J Biochem Biophys; 2009 Feb; 46(1):25-30. PubMed ID: 19374250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of arteries and veins in oxidative stress: producers, destroyers, function, and disease.
    Szasz T; Thakali K; Fink GD; Watts SW
    Exp Biol Med (Maywood); 2007 Jan; 232(1):27-37. PubMed ID: 17202583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative stress and vascular remodelling.
    Fortuño A; San José G; Moreno MU; Díez J; Zalba G
    Exp Physiol; 2005 Jul; 90(4):457-62. PubMed ID: 15890797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidative stress and human hypertension: vascular mechanisms, biomarkers, and novel therapies.
    Montezano AC; Dulak-Lis M; Tsiropoulou S; Harvey A; Briones AM; Touyz RM
    Can J Cardiol; 2015 May; 31(5):631-41. PubMed ID: 25936489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 66.